Juno Therapeutics, Inc. (Nasdaq: JUNO) announced in a presentation at the 58th American Society of Hematology (ASH) Annual Meeting encouraging ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE